AF3442 is a potent and selective mPGES-1 inhibitor ( IC 50 = 0.06 μM) which reduces monocyte PGE 2 generation also in the presence of plasma proteins. AF3442 shows selectivity over other prostanoids (TXB 2 , PGF 2α and 6-keto-PGF 1α ). AF3442 can be used for research in analgesia.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Pain | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > PGE synthase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.